Feldan Therapeutics collects C$16.5m in Series B financing

Feldan Therapeutics is a Quebec City-based biopharmaceutical company that develops treatments based on intracellular delivery of therapeutics.

14 June 2023•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.